Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.
Bacteriocins are antimicrobial peptides generally active against bacteria closely related to the producer. Escherichia coli produces two types of bacteriocins, colicins and microcins. The in vitro efficacy of isolated colicins E1, E6, E7, K and M, was assessed against Escherichia coli strains from patients with bacteraemia of urinary tract origin. Colicin E7 was most effective, as only 13% of the tested strains were resistant. On the other hand, 32%, 33%, 43% and 53% of the tested strains exhibited resistance to colicins E6, K, M and E1. Moreover, the inhibitory activity of individual colicins E1, E6, E7, K and M and combinations of colicins K, M, E7 and E1, E6, E7, K, M were followed in liquid broth for 24 hours. Resistance against individual colicins developed after 9 hours of treatment. On the contrary, resistance development against the combined action of 5 colicins was not observed. One hundred and five E. coli strains from patients with bacteraemia were screened by PCR for the presence of 5 colicins and 7 microcins. Sixty-six percent of the strains encoded at least one bacteriocin, 43% one or more colicins, and 54% one or more microcins. Microcins were found to co-occur with toxins, siderophores, adhesins and with the Toll/Interleukin-1 receptor domain-containing protein involved in suppression of innate immunity, and were significantly more prevalent among strains from non-immunocompromised patients. In addition, microcins were highly prevalent among non-multidrug-resistant strains compared to multidrug-resistant strains. Our results indicate that microcins contribute to virulence of E. coli instigating bacteraemia of urinary tract origin.
Department of Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Maruška
M
Budič
Matija
M
Rijavec
Ziva
Z
Petkovšek
Darja
D
Zgur-Bertok
D000890:Anti-Infective Agents / Q000378:metabolism / Q000494:pharmacology*; D016470:Bacteremia / Q000382:microbiology*; D001430:Bacteriocins / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology*; D003087:Colicins / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification* / Q000378:metabolism; D006801:Humans; D014552:Urinary Tract Infections / Q000382:microbiology; D037521:Virulence Factors / Q000378:metabolism
D000890:Anti-Infective Agents; D001430:Bacteriocins; D003087:Colicins; D037521:Virulence Factors